![James Boylan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
James P.
Boylan is Chief Executive Officer & Director at Enavate Sciences since 2022.
He is Independent Director at Immunome, Inc. since 2023, Independent Director at Compass Therapeutics, Inc. since 2022, Director at Graviton Bioscience Corp.
since 2024, Director at Zenas BioPharma (USA) LLC, and Independent Director at Zenas BioPharma, Inc. since 2022.
Former roles include Managing Director at Merrill Lynch & Co., Inc. from 1997 to 2009, Independent Director at CAMP4 Therapeutics Corp.
from 2022 to 2025, President & Head-Investment at SVB Securities Holdings LLC from 2009 to 2021, and President & Head-Investment Banking at Leerink Partners LLC from 2019 to 2021.
Education includes undergraduate studies at Lehigh University and an MBA from Columbia Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
IMMUNOME, INC. -.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
-.--% | 12/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/11/2022 |
| IMMUNOME, INC. | Direttore/Membro del Consiglio | 02/10/2023 |
Enavate Sciences
 Enavate Sciences Financial ConglomeratesFinance Invests and supports therapeutic & enabling technology companies | Amministratore Delegato | 01/05/2022 |
Zenas Pharma, Inc.
 Zenas Pharma, Inc. BiotechnologyHealth Technology Develops and markets immunology based therapies for patients | Direttore/Membro del Consiglio | - |
Graviton Bioscience Corp.
 Graviton Bioscience Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of autoimmune, cancer, genetic, fibrotic and other serious diseases | Direttore/Membro del Consiglio | 01/01/2024 |
| Società | Posizione | Fine |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Direttore/Membro del Consiglio | 09/09/2025 |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Presidente | 01/04/2021 |
SVB Securities Holdings LLC
 SVB Securities Holdings LLC Regional BanksFinance Operates as a bank holding company whose subsidiary provides investment banking services | Presidente | 01/04/2021 |
Merrill Lynch & Co., Inc. /Old/
 Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Corporate Officer/Principal | 01/05/2009 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
SVB Securities Holdings LLC
SVB Securities Holdings LLC Regional BanksFinance Operates as a bank holding company whose subsidiary provides investment banking services | Finance |
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
Compass Therapeutics, Inc.
 Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
Graviton Bioscience Corp.
Graviton Bioscience Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of autoimmune, cancer, genetic, fibrotic and other serious diseases | Health Technology |
Enavate Sciences
Enavate Sciences Financial ConglomeratesFinance Invests and supports therapeutic & enabling technology companies | Finance |
Zenas Pharma, Inc.
Zenas Pharma, Inc. BiotechnologyHealth Technology Develops and markets immunology based therapies for patients | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
